BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3799933)

  • 1. Pitted red cell counts in sickle cell disease. Relationship to age, hemoglobin genotype, and splenic size.
    Fatunde OJ; Scott RB
    Am J Pediatr Hematol Oncol; 1986; 8(4):329-33. PubMed ID: 3799933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease.
    West MS; Wethers D; Smith J; Steinberg M
    J Clin Epidemiol; 1992 Aug; 45(8):893-909. PubMed ID: 1624972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early rise in the "pitted" red cell count as a guide to susceptibility to infection in childhood sickle cell anaemia.
    Rogers DW; Serjeant BE; Serjeant GR
    Arch Dis Child; 1982 May; 57(5):338-42. PubMed ID: 7092288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitted red cell counts in Nigerian children with sickle cell anemia: correlation with age and splenic size.
    Adekile AD; Reindorf CA; Adeodu OA; Johnson W; Dairo BA
    J Natl Med Assoc; 1991 Apr; 83(4):329-31. PubMed ID: 1920505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen function in children with sickle B+ thalassemia.
    Barrios NJ; Kirkpatrick DV; Lohman D; McMullen CC; Wilson W; Humbert JR
    J Natl Med Assoc; 1991 Sep; 83(9):819-22. PubMed ID: 1942116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic function in sickle-cell diseases.
    Zago MA; Bottura C
    Clin Sci (Lond); 1983 Sep; 65(3):297-302. PubMed ID: 6872464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental pattern of splenic dysfunction in sickle cell disorders.
    Pearson HA; Gallagher D; Chilcote R; Sullivan E; Wilimas J; Espeland M; Ritchey AK
    Pediatrics; 1985 Sep; 76(3):392-7. PubMed ID: 2412200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.
    Oudat RI; Abualruz HS; Al-Shiek NKA; Al-Mashaqba EA; Al-Hiari RA; Alsoukhni HA; Hammad MAA
    Med Arch; 2021 Feb; 75(1):27-30. PubMed ID: 34012195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitted red cell counts in Nigerian children with sickle cell anaemia: correlation with age and splenic size.
    Adekile AD; Adeodu RO; Johnson W; Dairo BA
    West Afr J Med; 1991; 10(2):137-40. PubMed ID: 1911481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxinaemia in sickle cell disease.
    Thomson AP; Dick M
    Clin Lab Haematol; 1988; 10(4):397-401. PubMed ID: 3074892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The red cell distribution width in sickle cell disease--is it of clinical value?
    Thame M; Grandison Y; Mason K; Thompson M; Higgs D; Morris J; Serjeant B; Serjeant G
    Clin Lab Haematol; 1991; 13(3):229-37. PubMed ID: 1794225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional asplenia in hemoglobin SC disease.
    Lane PA; O'Connell JL; Lear JL; Rogers ZR; Woods GM; Hassell KL; Wethers DL; Luckey DW; Buchanan GR
    Blood; 1995 Apr; 85(8):2238-44. PubMed ID: 7718896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of splenic function by transfusion in two young adults with sickle cell anemia.
    Wethers DL; Grover R
    Am J Pediatr Hematol Oncol; 1987; 9(3):209-11. PubMed ID: 3674332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome.
    Honig GR; Koshy M; Mason RG; Vida LN
    J Pediatr; 1978 Apr; 92(4):556-61. PubMed ID: 633012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
    Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
    Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival.
    Brewin JN; Nardo-Marino A; Stuart-Smith S; El Hoss S; Hanneman A; Strouboulis J; Menzel S; Gibson JS; Rees DC
    Am J Hematol; 2022 Oct; 97(10):1275-1285. PubMed ID: 35802781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of splenic phagocytic function in Brazilian patients with sickle cell disease.
    Grotto HZ; Costa FF
    Rev Paul Med; 1992; 110(6):262-6. PubMed ID: 1341023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.